抗SRP抗体陽性ミオパチー(anti-SRP myopathy):筋炎との相違点

書誌事項

タイトル別名
  • Anti-SRP myopathy: different entity from myositis

この論文をさがす

説明

Anti-signal recognition particle (SRP) antibody, detected in 5-8% of patients with clinical diagnosis of myositis, had been associated with severe and refractory myositis. However, it has been accepted that anti-SRP myopathy should be separated from myositis based on histological features of necrotizing myopathy. We reviewed clinical features of 27 patients with anti-SRP myopathy, and analyzed disease progression and neurological outcome. Anti-SRP antibodies in serum were detected by RNA immunoprecipitation assay using extracts of K562 cells. Of the 27 patients, 5 (18.5%) showed chronic progressive muscle weakness as well as atrophy of limbs and trunk muscles from a younger age with more severe neurological outcomes compared to the other 22 patients with the subacute form. A subset of patients with anti-SRP myopathy can show a chronic progressive form associated with severe clinical deficits.<br>

収録刊行物

  • 臨床神経学

    臨床神経学 52 (11), 1148-1150, 2012

    日本神経学会

被引用文献 (1)*注記

もっと見る

参考文献 (8)*注記

もっと見る

詳細情報 詳細情報について

  • CRID
    1390001205036049920
  • NII論文ID
    130004505088
  • DOI
    10.5692/clinicalneurol.52.1148
  • COI
    1:STN:280:DC%2BC3s7ns1yqtg%3D%3D
  • ISSN
    18820654
    0009918X
  • PubMed
    23196545
  • 本文言語コード
    ja
  • 資料種別
    journal article
  • データソース種別
    • JaLC
    • Crossref
    • PubMed
    • CiNii Articles
    • OpenAIRE
  • 抄録ライセンスフラグ
    使用不可

問題の指摘

ページトップへ